EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Conditions: Type 2 Diabetes; Obesity Interventions: Other: Weight Management Program (WMP); Other: Traditional care; Drug: Phentermine / Topiramate Extended Release Oral Capsule; Drug: naltrexone/bupropion extended-release; Drug: liraglutide 3.0 mg; Drug: Orlistat Sponsor: The Cleveland Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adipex | Alli | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Obesity | Phentermine | Research | Topamax | Xenical